148 related articles for article (PubMed ID: 34911023)
21. Emerging pan-resistance in Trichosporon species: a case report.
Oliveira dos Santos C; Zijlstra JG; Porte RJ; Kampinga GA; van Diepeningen AD; Sinha B; Bathoorn E
BMC Infect Dis; 2016 Apr; 16():148. PubMed ID: 27074951
[TBL] [Abstract][Full Text] [Related]
22. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
[TBL] [Abstract][Full Text] [Related]
23. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM
Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
[TBL] [Abstract][Full Text] [Related]
24. [Nosocomial infection due to Trichosporon asahii in a critical burned patient].
Tamayo Lomas L; Domínguez-Gil González M; Martín Luengo AI; Eiros Bouza JM; Piqueras Pérez JM
Rev Iberoam Micol; 2015; 32(4):257-60. PubMed ID: 25579090
[TBL] [Abstract][Full Text] [Related]
25. Invasive Infections Due to
Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
[TBL] [Abstract][Full Text] [Related]
26. Orthopedic infections due to Trichosporon species: Case series and literature review.
Mello López A; da Silva Neto LA; de Oliveira VF; de Carvalho VC; de Oliveira PRD; Lima ALLM
Med Mycol; 2022 Dec; 61(1):. PubMed ID: 36610725
[TBL] [Abstract][Full Text] [Related]
27. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
[TBL] [Abstract][Full Text] [Related]
28. Fungaemia due to rare yeasts in a tertiary care university centre within 18 years.
Alp S; Gulmez D; Ayaz CM; Arikan-Akdagli S; Akova M
Mycoses; 2020 May; 63(5):488-493. PubMed ID: 32145101
[TBL] [Abstract][Full Text] [Related]
29. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
30. Trichosporon inkin as an Emergent Pathogen in Patients With Severe Pemphigus.
Nobrega de Almeida Júnior J; Buccheri de Oliveira R; Duarte A; Lopes Motta A; Rossi F; Sachiko Yamamoto de Figueiredo D; Barbaro Del Negro GM; Aoki V; Wakisaka Maruta C; Giuli Santi C; Benard G
JAMA Dermatol; 2015 Jun; 151(6):642-5. PubMed ID: 25785367
[TBL] [Abstract][Full Text] [Related]
31. Trichosporonosis in Pediatric Patients With a Hematologic Disorder.
Foster CE; Edwards MS; Brackett J; Schady DA; Healy CM; Baker CJ
J Pediatric Infect Dis Soc; 2018 Aug; 7(3):199-204. PubMed ID: 28510690
[TBL] [Abstract][Full Text] [Related]
32.
Santos FA; Leite-Andrade MC; Vasconcelos MA; Alves AI; Buonafina-Paz MD; Araújo-Neto LN; Macêdo DP; Neves RP
Future Microbiol; 2022 Jan; 17():81-87. PubMed ID: 34913372
[TBL] [Abstract][Full Text] [Related]
33. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
34. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of
Feugray G; Krzisch D; Dehais M; Razakandrainibe R; Gargala G; Favennec L; Lepretre S; Camus V; Costa D
Infect Drug Resist; 2019; 12():2015-2018. PubMed ID: 31372009
[No Abstract] [Full Text] [Related]
36. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
37. Two Case Presentations Infected by Trichosporon asahii and Treated with Voriconazole Successfully.
Tanyildiz HG; Yesil S; Toprak S; Candir MO; Sahin G
Case Rep Infect Dis; 2015; 2015():651315. PubMed ID: 26351595
[TBL] [Abstract][Full Text] [Related]
38. [An overview on Trichosporon asahii and its infections].
Hazırolan G
Mikrobiyol Bul; 2012 Oct; 46(4):707-15. PubMed ID: 23188586
[TBL] [Abstract][Full Text] [Related]
39. Chemoport-related Fungemia Caused by Trichosporon asahii.
Raju DS; Sugunan A; Keechilattu P; Philip A; Reghu R
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e193-e194. PubMed ID: 30676435
[TBL] [Abstract][Full Text] [Related]
40. Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Rieger C; Geiger S; Herold T; Nickenig C; Ostermann H
Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):843-5. PubMed ID: 17690928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]